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Abstract: The title chalcone (E)-1-(2-aminophenyl)-3-(benzo[d][1,3]dioxol-5-yl)prop-2-en-1-one was
obtained in 76% yield from a NaOH catalyzed Claisen–Schmidt condensation reaction between
o-aminoacetophenone and piperonal. This product will be used as a key precursor for the
development of an alternative route for the total synthesis of the alkaloid Graveoline. Single crystals of
the title compound suitable for X-ray diffraction were grown via slow evaporation in ethanol at room
temperature. A complete crystallographic study was performed in depth to unequivocally confirm
its structure. The crystal structure of the title o-aminochalcone, C16H13NO3, shows two molecules
per asymmetric unit (Z = 4) and adopts an E configuration about the C=C double bond. In the title
compound, the mean plane of the non-H atoms of the central chalcone fragment C—C(O)—C—C—C
is as follow: [root-mean-square (r.m.s.) deviation = 0.0210 Å for A–B and 0.0493 for C–D molecules].
In the crystal, molecules are linked by N–H...O and C–H...O, hydrogen bonds forming S(6), R22(6)
and edge-fused R44(24)rings along with C(18) chains running parallel to (110).
Keywords: o-aminoacetophenones; benzodioxolyl moiety; Claisen–Schmidt condensation;
o-aminochalcones; single crystal X-ray diffraction
1. Introduction
Chalcones are synthetic or naturally occurring α,β-unsaturated diaryl ketones which have shown
a wide spectrum of biological [1–4] and synthetic [5,6] properties. It has been found that their biological
activities and those of their derivatives may be enhanced by the insertion of heterocyclic rings in their
structures [7]. Thus, chalcones bearing the heterocyclic [1,3]-dioxolo functionality are of particular
interest because diverse synthetic and natural compounds containing this functionality in their
frameworks have displayed important biological and pharmacological properties [8,9]. Continuing
with our current studies on the synthetic utility of o-aminochalcones [10,11], the amino-[1,3]-dioxolo
derivative 3was obtained (as precursor for alkaloid Graveoline), from the condensation reaction of
o-aminoacetophenone 1 and piperonal 2 in ethanolic alkaline media, (Scheme 1).
2. Results and Discussion
Chalcone 3 was previously prepared in 82% yield (m.p. 112 ◦C) by Tókés and Forró [12] for
diverse bromination studies involving the formation of the tetrahydroquinolone 4, (Entry 1, Scheme 1).
Posteriorly, Bunce and Nammalwar [13] obtained chalcone 3 as a side-product in 46% yield
Molbank 2017, 2017, M924; doi:10.3390/M924 www.mdpi.com/journal/molbank
Molbank 2017, 2017, M924 2 of 6
(m.p. 110–112 ◦C), attempting to synthesize the quinolone 4 through an in situ tandem
reduction–Michael addition reaction in acetic acid media, (Entry 2, Scheme 1).
In this work, compound 3 was synthesized as a key intermediate for an alternative route of
synthesis of alkaloid Graveoline and related methylenedioxy 2-aryl-4-quinolones. This product was
obtained in 76% yield from equimolar amounts of o-aminoacetophenone 1 and piperonal 2 via a NaOH
catalyzed Claisen–Schmidt condensation reaction as shown in Scheme 1, Entry 3. The residue was
crystallized from ethanol affording a yellow solid. Single crystals of 3 suitable for X-ray diffraction
were grown via slow evaporation of the ethanolic mother liquor.
Ȯ Ȯ
Ȯ
 
 
Scheme 1. Routes for the synthesis of the o-aminochalcone 3.
Although compound 3 was acceptably characterized in references [12,13], some differences with
our experimental data were found and no crystallographic analysis was supplied. These findings
encouraged us to grow crystals of chalcone 3 suitable for X-ray diffraction. Additionally, a complete
analytical and spectroscopic characterization (i.e., IR, 1D and 2D NMR, mass and elemental analysis)
of compound 3was performed; see Materials and Methods section.
2.1. Structural Analysis
Single crystals of 3 suitable for X-ray diffraction were grown via slow evaporation in ethanol at
room temperature. According to the results (Figures 1 and 2 and Tables 1 and 2), there is no doubt that
the obtained compound effectively corresponds to chalcone 3 as suggested in Scheme 1, (Entry 3).
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Figure 1. Oak Ridge Thermal Ellipsoids Program (ORTEP) drawing of the asymmetric unit for the
o-aminochalcone 3; ellipsoids are displayed at the 50% probability level.
Table 1. Selected bond lengths [Å], angles [◦] and torsion angles [◦] for chalcone 3.
Bond Lengths
C1-C7; 1.4696(18) C17-C23; 1.4712(18)
C7-O1; 1.2445(16) C23-O4; 1.2431(16)
C8-C9; 1.3334(19) C24-C25; 1.3322(19)
C9-C10; 1.4553(19) C25-C26; 1.4570(18)
C10-C15; 1.3949(18) C26-C31; 1.3966(18)
O2-C12; 1.3608(17) O5-C28; 1.3691(16)
O3-C13; 1.3662(17) O6-C29; 1.3663(16)
C11-C12; 1.3591(19) C27-C28; 1.3611(19)
C13-C14; 1.363(2) C29-C30; 1.3647(19)
Angles
C7-C8-C9; 122.35(13) C17-C23-C24; 119.00(12)
C8-C9-C10; 126.41(13) C24-C25-C26; 126.36(13)
Torsion Angles
N1-C2-C1-C7; -2.2(2) N2-C18-C17-C23; −0.57(18)
C2-C1-C7-O1; 1.9(2) C18-C17-C23-O4; 7.32(18)
Similar compounds to 3 have previously been reported in the literature (i.e., 1-(6-amino-1,3-
benzodioxol-5-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one [14] and 1-(6-amino-1,3-benzodioxol-
5-yl)-3-(4-methoxyphenyl)prop-2-en-1-one [15]). The title compound 3 crystallizes in triclinic, P1, with
Z = 4. In the molecular structure of 3 shown in Figure 1, the central fragments C1–C7(O1)–C8=C9–C10
and C17–C23(O2)–C24=C25–C6 are essentially planar (root-mean-square (r.m.s.) deviation for all
non-H atoms = 0.0210 Å and 0.0493 Å respectively) and they form dihedral angles of 1.47(9)◦
and 7.79(15)◦ with the A and C aryl rings, respectively and 4.86(9)◦ and 2.09(15)◦ with the B and
D benzodioxol rings, respectively. The amino groups are syn positioned with respect to the carbonyl
groups in both molecules.
Bond lengths and bond angles in the title molecules are in good agreement with those found
in the related compounds of the references [14,15], with the exception of the C10–C15 and C26–C31
bond lengths. Whereas the title structure exhibits shortened distances of 1.3949(18) and 1.3966(18) Å,
respectively, in these compounds, such bond lengths are 1.426(3) and 1.430(3) Å, respectively.
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2.2. Supramolecular Features
The packing arrangement of the title compound can be described by strong intramolecular
N–H...O hydrogen bonds and by intermolecular N–H...O and C–H...O hydrogen bonds of
medium-strength (see Table 1), [16]. The two molecules of the asymmetric unit intertwine to form
intra-intermolecular intercalated bonds, generating S(6) and R44(24) rings [17]. In these interactions,
the N2–H3N moiety in the molecule at (x,y,z) acts as a hydrogen-bond donor to the O1 atom of the
carbonyl group at (x,y,z) and N1–H1N in the molecule at (x,y,z) acts as a hydrogen-bond donor to
the O4 atom of the carbonyl group at (2 − x, 1 − y, 1 − z). Molecules are connected and they are
related by an inversion center, forming a kind of inner ring as seen in Figure 2. One of the molecules
of the asymmetric unit proceeds to join, via C32–H32...O5 bonds with its twin molecule, configuring
dimers with R22-(6) rings. Thus, the inner rings are attached to C(18) chains of molecules, forming
sheets running parallel to (110).
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Figure 2. Part of the crystal structure of 3, showing the formation of S(6), R22 (6) and R
4
4-(24) rings along
with C(18) chains running parallel to (010). (Symmetry codes: (i) 2 − x, 1 − y, 1 − z; (ii) −x, 3 − y,
1 − z).
Table 2. Hydrogen bond lengths [Å] and angles [◦] for o-aminochalcone 3.
D–H...A D–H H...A D...A D–H...A
N2-H3N . . . O1 0.899(18) 2.132(19) 3.0293(16) 175.8(16)
N1-H1N . . . O4i 0.88(2) 2.22(2) 3.0254(17) 152.6(16)
C32-H32B . . . O5ii 0.99 2.49 3.3497(17) 144.9
Symmetry codes: (i) 2 − x, 1 − y, 1 − z; (ii) −x, 3 − y, 1 − z.
3. Materials and Methods
3.1. General Information
The melting point was determined on a Büchi melting point B-450 apparatus (Instrumart, South
Burlington, VT, USA) and is uncorrected. The FTIR spectrum was recorded on a Shimadzu FTIR 8400
spectrophotometer (Scientific Instruments Inc., Seattle, WA, USA) using KBr disks. 1H- and 13C-NMR
spectra were recorded on a Bruker Avance 400 spectrometer (Bruker BioSpin GmbH, Rheinstetten,
Germany) operating at 400 MHz and 100 MHz, respectively, and using DMSO-d6 as solvent and
tetramethylsilane as an internal standard. The mass spectrum was obtained on a SHIMADZU-GCMS
2010-DI-2010 spectrometer (Scientific Instruments Inc., Columbia, IN, USA), equipped with a direct
inlet probe) operating at 70 eV. Microanalysis was performed on a Thermo-Finnigan Flash EA1112
CHN elemental analyzer (Thermo Fischer Scientific Inc., Madison, WI, USA), and the values are within
±0.4% of the theoretical values. Silica gel aluminum plates (Merck 60 F254, Darmstadt, Germany) were
used for analytical Thin Layer Chromatography (TLC). The starting ketone 1 and aldehyde 2 were
Molbank 2017, 2017, M924 5 of 6
purchased from (Sigma-Aldrich, San Luis, MO, USA); analytical or reagent grades were used without
further purification.
3.2. Synthesis of (E)-1-(2-Aminophenyl)-3-(benzo[d][1,3]dioxol-5-yl)prop-2-en-1-one (3)
A mixture of o-aminoacetophenone 1 (0.5 g, 1 mmol), piperonal 2 (1 mmol), 20% NaOH aqueous
solution (0.5 mL), and 96% EtOH (5 mL) was subjected to reflux for 20 min. The solid formed was
filtered and washed with water then with ethanol. Recrystallization from 96% ethanol afforded 3
(76% ield, yellow solid, m.p. 117 ◦C). FTIR (KBr): ν = 3425, 3309 (NH2), 3070, 2904, 1633 (C=O),
1601, 1566, 1244 and 1207 (CO) cm−1. 1H-NMR (400 MHz, DMSO-d6) δ: 6.11 (s, 2H, OCH2O, H-16),
6.60 (t, J = 8.0 Hz, 1H, H-5), 6.81 (d, J = 8.0 Hz, 1H, H-3), 6.98 (d, J = 8.0 Hz, 1H, H-14), 7.26–7.29 (m, 2H,
H-15, H-4), 7.38 (s, 2H, NH2), 7.59 (d, J = 16.0 Hz, 1H, H-9), 7.63 (s, 1H, H-11), 7.84 (d, J = 16.0 Hz,
1H, H-8), 8.11 (d, J = 8.0 Hz, 1H, H-6) ppm. 13C-NMR (100 MHz, DMSO-d6) δ: 102.0 (C-16, OCH2O),
107.4 (C-11), 108.9 (C-14), 114.9 (C-5), 117.3 (C-3), 118.2 (C-2), 121.8 (C-8), 125.8 (C-15), 130.1 (C-1),
131.9 (C-6), 134.6 (C-4), 142.5 (C-9), 148.6 (C-12), 149.6 (C-13), 152.5 (C-10), 191.0 (C-7, C=O) ppm.
The numbering of the C and H atoms is the same as that for structure 3 in Figure 1. Anal. calcd. for
C16H13NO3 (267.27): C, 71.90; H, 4.90; N, 5.24. Found: C, 72.03; H, 4.77; N, 5.35. MS (EI, 70 eV) m/z (%):
267 (31) [M+], 266 (50), 146 (100).
Crystal Data: C16H13NO3 (M = 267.27 g/mol): triclinic, space group P1 (no. 2), a = 7.7323(3) Å,
b = 11.2145(5) Å, c = 15.1819(7) Å, V = 1276.36(10) Å3, Z = 4, T = 123(2) K, µ(MoKα) = 0.097 mm−1,
Dcalc = 1.391 Mg/m3, 11,674 reflections measured (3.028◦ ≤ θ ≤ 27.497◦), 5794 unique (Rint = 0.0185,
Rsigma = 0.0317) which were used in all calculations. The final R1 was 0.0413 (I > 2σ(I)) and wR2 was
0.0554 (all data).
Data Collection and Refinement Details: Diffraction data were collected on an Oxford Diffraction
Xcalibur E diffractometer [18], using graphite monochromated MoKα radiation (0.71073 Å).
The corrected data were solved by direct methods with SHELXS-97 and refined by full-matrix methods
on F2 with SHELXL-2014 [19]. All H-atoms, except for H–N, were positioned at geometrically idealized
positions, C–H = 0.9500 Å, C16-H = 0.9900 Å and C32-H = 0.9900 Å and were refined using a riding
model approximation with Uiso(H) = 1.2 Ueq(parent atom). H–N atoms were found from the Fourier
difference maps, and their coordinates were freely refined. Correctness of the model was confirmed
by low residual peaks (0.257) and holes (−0.203 e. Å−3) in the final difference map. (CCDC 1518500
contains the supplementary crystallographic data for this paper. These data can be obtained free of
charge via http://www.ccdc.cam.ac.uk/conts/retrieving.html or from the CCDC, 12 Union Road,
Cambridge CB2 1EZ, UK; Fax: +44 1223 336033; E-mail: deposit@ccdc.cam.ac.uk.)
Supplementary Materials: Copies of the IR, 1H-, 13C-NMR, DEPT-135, 2D NMR and mass spectra and the
checkCIF and CIF files for compound 3 can be found at www.mdpi.com/1422-8599/2017/1/M923.
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